Professional Documents
Culture Documents
Open Bionics LTD Open Bionics Financial Outlook 2023 To 2026
Open Bionics LTD Open Bionics Financial Outlook 2023 To 2026
25,000.0
20,000.0
### 2022
2023 2024 2025 2026
15,000.0
5,000.0
00.0
2021 2022 2023 2024 2025 2026
-5,000.0
Revenue EBITDA
No. Units Sold 111 135 - 24 283 148 679 396 1,233 1,233 1,901 1,901
Total Revenue 1,020.4 965.5 3,572.9 7,462.3 14,146.2 21,904.6 2022 Product
NewRevenue
markets
Market Blended
Volume
Pricing
growth
2023 Product Revenue
Gross Profit 690.7 660.2 2,513.5 5,035.5 9,580.3 14,767.3 884.2 549.1 736.8 1,137.7 3,307.9
Gross Margin 68% 68% -1% 70% 3% 67% -3% 68% 0% 67% 0%
Other Operating Income 32.2 5.3
Other Income (inc Grants) 35.5 171.8
Indirect Payroll (inc Consultants) 1,736.3 1,293.5 -442.8 3,530.1 -1,793.8 4,710.7 -1,180.6 6,483.5 -1,772.8 8,754.1 -2,270.7
Overheads 1,295.9 937.9 -358.1 2,188.0 -1,250.2 2,603.4 -415.3 3,497.9 -894.5 4,688.6 -1,190.7
EBITDA -2,273.9 -1,394.1 -3,204.6 -2,278.6 -401.0 1,324.6
Interest 0.1 -6.5 0.9 0.7 0.4 0.2
Depreciation & Amortisation 44.2 47.1 43.8 42.1 49.6 62.5 Warranty Income
Profit Before Tax -2,318.1 -1,434.6 -3,249.3 -2,321.3 -451.1 1,262.0 136.2 265.0
Tax -145.0 -215.0 -129.5 -148.0 -245.0 122.2 Total Revenue
Profit After Tax -2,173.1 -1,219.6 -3,119.8 -2,173.3 -206.1 1,139.8 1,020.4 3,572.9
£'000s 2022 2021 2023 2024 2025 2026
Fixed Assets 147.3 171.6 130.5 136.5 152.9 168.4
Stock 245.0 114.1 355.0 455.0 575.0 560.0
Trade Debtors 144.4 146.9 599.1 1,395.3 2,718.9 4,460.6
R&D Tax Debtor 145.0 168.2 129.5 148.0 245.0 129.5
Prepayments & Other Debtors 185.9 264.4 290.7 334.2 422.6 540.1
Cash at Bank 1,952.0 799.1 1,878.6 296.4 1,224.0 3,358.5
Trade Creditors 128.9 332.3 230.6 280.8 396.9 542.1
Warranty Accrual 443.1 250.1 1,507.9 2,979.6 5,599.8 7,859.4
Other Creditors 395.7 250.3 617.1 660.6 713.2 805.9
Corporation Tax 251.7
Loans 43.3 50.0 32.5 22.5 12.5 2.5
Share Capital & Premium 8,007.8 4,810.2 10,314.4 10,314.4 10,314.4 10,314.4
Retained Profit/(Loss) -4,026.1 -2,809.0 -6,199.2 -9,319.1 -11,492.4 -11,698.5
Current Year Earnings -2,173.1 -1,219.6 -3,119.8 -2,173.3 -206.1 1,139.8
1,808.5 781.6 995.3 -1,178.0 -1,384.1 -244.3
Check 0.0 0.0 0.0 0.0 0.0 0.0
EBITDA -2,273.9 -3,204.6 -2,278.6 -401.0 1,324.6
stock (increase)/decrease -130.9 -110.0 -100.0 -120.0 15.0
debtors (increase)/decrease 54.4 -559.6 -839.7 -1,412.0 -1,859.3
creditors increase/(decrease) 320.2 1,387.9 1,565.4 2,789.0 2,497.4
from operating activities -2,030.1 -2,486.3 -1,652.9 856.0 1,977.7
Net Interest (paid)/received -0.1 -0.9 -0.7 -0.4 -0.2
Capex -20.0 -27.0 -48.0 -66.0 -78.0
Financing 3,190.9 2,295.8 -10.0 -10.0 -10.0
Taxation 168.2 145.0 129.5 148.0 245.0
Increase/(decrease) in cash 1,309.0 -73.4 -1,582.1 927.6 2,134.5
Cash b/f 799.1 1,952.0 1,878.6 296.4 1,224.0
Cash c/f 2,108.0 1,878.6 296.4 1,224.0 3,358.5
Check 0.0 0.0 0.0 0.0 0.0